Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135056) titled 'A Human Bioequivalence Study of Nilotinib Capsules' on Oct. 23.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: the Second Affiliated Hospital of Soochow University
Condition:
Chronic Myeloid Leukemia
Intervention:
TR Group:Take the test product (T)in the first period, and reference product (R) in the second period.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-11
Target Sample Size: TR Group:15;RT Group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=336389
Disclaimer: Curated by HT ...